Salix Pharmaceuticals received an FDA approval for Metozolv (metoclopramide), a treatment for diabetic gastroparesis and gastroesophageal reflux disease (GERD). The drug was approved for short-term use, from four to 12 weeks.
Novartis is apologizing to Japan after the Ministry of Health, Labor and Welfare said the company had dragged its feet reporting adverse events for two of its cancer drugs.
The company is calling the move a withdrawal, as opposed to a recall.
The meningitis and encephalitis medications earned a combined $300 million last year.